Brad Middlekauff

Brad Middlekauff is an experienced Chief Business Officer and General Counsel in the biotechnology industry, with a background in legal counsel, strategic planning, and business development. Their career spans across various companies in the biotech sector, including Nasdaq-listed companies and start-ups. Brad has been involved in developing antibody-based products for autoimmune diseases and cancer, as well as being a board member for a biotechnology company focused on immunotherapies. Brad Middlekauff also has experience in advisory roles at educational institutions such as Princeton University.